Notably, one sample (ID074) with an extremely high level of BCL2L1, was collected from a PB of a patient presenting mutations in BRCA2, IDH2, and RUNX1, and the lowest number of WBC in the whole group of the AML patients. Here, BCL2L1 is linked to acute myeloid leukemia.